Novo Nordisk
NVO
425 hedge funds and large institutions have $6.26B invested in Novo Nordisk in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 165 increasing their positions, 140 reducing their positions, and 35 closing their positions.
51% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 35
18% more repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 140
8% more capital invested
Capital invested by funds: $5.8B → $6.26B (+$452M)
3% more funds holding
Funds holding: 411 → 425 (+14)
9% more call options, than puts
Call options by funds: $66.4M | Put options by funds: $61M
1.29% less ownership
Funds ownership: 84.64% → 83.35% (-1.3%)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$69.7M |
| 2 |
Renaissance Technologies
New York
|
+$57.5M |
| 3 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
+$36.2M |
| 4 |
CCM
Chautauqua Capital Management
Boulder,
Colorado
|
+$25.1M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$23.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$178M |
| 2 |
Jane Street
New York
|
-$40.8M |
| 3 |
O
OppenheimerFunds
New York
|
-$32.9M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$17.4M |
| 5 |
Bank of New York Mellon
New York
|
-$16.8M |
NVO Hedge Fund Activity: Q3 2013 in Review
425 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2013, worth a combined $6.26B — up 7.8% from $5.8B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new NVO positions and 35 closed out — a net gain of 18 holders — while 165 added to existing stakes and 140 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $69.7M. The largest seller was Jennison Associates, cutting an estimated $178M.
- 425 institutional investors held Novo Nordisk (NVO) as of Q3 2013, up from 411 in Q2 2013.
- Funds reported $6.26B of Novo Nordisk stock for Q3 2013, up 7.8% quarter-over-quarter.
- 53 funds opened new Novo Nordisk positions in Q3 2013 and 35 closed out, a net change of +18 holders.
- The largest Novo Nordisk buyer in Q3 2013 was Lazard Asset Management, an estimated $69.7M added.
- The largest Novo Nordisk seller in Q3 2013 was Jennison Associates, an estimated $178M sold.
Based on aggregated 13F filings for Q3 2013.